Colombia Sets Dangerous Precedent With Move To Disregard Privately Held Patents
By: Sara Croom
On Friday, the Colombian government announced it would issue a “public interest declaration” allowing their nation to forcefully set a lower price on Novartis’s lifesaving cancer drug Glivec. This move flies in face of the legal bind between private industry,...